HOME >> BIOLOGY >> NEWS
'Electric' fish shed light on ways the brain directs movement

Scientists have long struggled to figure out how the brain guides the complex movement of our limbs, from the graceful leaps of ballerinas to the simple everyday act of picking up a cup of coffee. Using tools from robotics and neuroscience, two Johns Hopkins University researchers have found some tantalizing clues in an unlikely mode of motion: the undulations of tropical fish.

Their findings, published in the January 31 issue of the Journal of Neuroscience, shed new light on the communication that takes place between the brain and body. The fish research may contribute to important medical advances in humans, including better prosthetic limbs and improved rehabilitative techniques for people suffering from strokes, cerebral palsy and other debilitating conditions.

"All animals, including humans, must continually make adjustments as they walk, run, fly or swim through the environment. These adjustments are based on feedback from thousands of sense organs all over the body, providing vision, touch, hearing and so on. Understanding how the brain processes this overwhelming amount of information is crucial if we want to help people overcome pathologies," said Noah Cowan, an assistant professor of mechanical engineering in Johns Hopkins' Whiting School of Engineering. In studying the fish and preparing the Neuroscience paper, Cowan teamed up with Eric Fortune, assistant professor of psychological and brain sciences in the Krieger School of Arts and Sciences, also at Johns Hopkins.

Cowan and Fortune focused on the movements of a small, nocturnal South American fish called the "glass knifefish" because of its almost transparent, blade-shaped body. This type of fish does something remarkable: it emits weak electrical signals which it uses to "see" in the dark. According to Fortune, several characteristics, including this electric sense, make this fish a superb subject for the study of how the brain uses sensory information to control locom
'"/>

Contact: Lisa De Nike
LDE@jhu.edu
443-287-9960
Johns Hopkins University
31-Jan-2007


Page: 1 2 3

Related biology news :

1. Other highlights in the Aug. 7 JNCI
2. Research team enlightens the reasons for severe blindness
3. Coelacanth fossil sheds light on fin-to-limb evolution
4. Molecule blocks gene, sheds light on liver cancer
5. ESA mission highlighted at remote sensing conference
6. Surprising new species of light-harvesting bacterium discovered in Yellowstone
7. Other highlights in the July 24 JNCI
8. Enzyme discovery sheds light on vitamin D
9. Study sheds light on why humans walk on two legs
10. Other highlights from the July 10 JNCI
11. Internal clock, external light regulate plant growth

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Electric fish shed light ways the brain directs movement

(Date:4/1/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces the second shipment ... underway to early access pre-order customers. ... retail outlets including Walmart, Target, AT&T, Dunkin, Donuts, Stop ... accepted at all outlets and very easy to use. ...
(Date:3/26/2015)... -- The Granite Club, Canada,s ... today announced it has implemented a state-of-the-art access and ... members and staff, while restricting access to authorized users ... FST,s IMID Access system because it has the perfect ... staff, in addition to unparalleled security," said James ...
(Date:3/23/2015)... Mass , March 23, 2015 SoundView Technology ... of NXT-ID,s (NASDAQ: NXTD ) Wocket smart wallet. SoundView was ... user feedback on their experience with the Wocket in multiple ... at CVS, Whole Foods and other retailers, making both debit ... Kris Tuttle also says, "If the company meets their ...
Breaking Biology News(10 mins):NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4
(Date:4/16/2015)... April 16, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... U.S. joint venture with G-treeBNT (ReGenTree LLC) has ... clinical trial for the orphan disorder, neurotrophic keratopathy ... dry eye syndrome (DES) in the U.S.  Both ... RGN-259/GBT201, this year.  Each of these eye disorders ...
(Date:4/16/2015)... 16, 2015  AnaptysBio, Inc., a leader in ... today announced the advancement of its first-in-class ... studies. The Company,s anti-IL-36R therapeutic antibody, called ... pustular psoriasis (GPP), an orphan systemic inflammatory ... wholly owned within AnaptysBio,s proprietary antibody pipeline ...
(Date:4/16/2015)... Switzerland , April 16, 2015 ... of Debiopharm Group ™ , a Swiss-based global ... unmet medical needs as well as companion ... the investigational compounds Debio 1143 (SMAC mimetic) and ... at the 2015 Annual meeting of the ...
(Date:4/16/2015)... Washington (PRWEB) April 16, 2015 ... Applied Cancer Science and Resolution Bioscience, Inc. today ... to co-develop a novel, blood-based, clinic ready, Next ... cancer (NSCLC). The collaboration is the first to ... RET, and ROS1 fusions in blinded plasma samples ...
Breaking Biology Technology:RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 3Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer 2Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer 3
Cached News: